AURON Trademark

Trademark Overview

On Sunday, December 12, 2021, a trademark application was filed for AURON with the United States Patent and Trademark Office. The USPTO has given the AURON trademark a serial number of 97168359. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Tuesday, July 8, 2025. This trademark is owned by Auron Therapeutics, Inc.. The AURON trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
auron

General Information

Serial Number97168359
Word MarkAURON
Filing DateSunday, December 12, 2021
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateTuesday, July 8, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 1, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 16, 2021
Primary Code005
First Use Anywhere DateWednesday, May 7, 2025
First Use In Commerce DateWednesday, May 7, 2025

Trademark Owner History

Party NameAuron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewton, MA 02458
Party NameAuron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWellesley, MA 01908

Trademark Events

Event DateEvent Description
Thursday, December 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 15, 2021NEW APPLICATION ENTERED
Monday, September 19, 2022ASSIGNED TO EXAMINER
Wednesday, September 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 12, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 1, 2022PUBLISHED FOR OPPOSITION
Tuesday, December 27, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, May 2, 2023SOU EXTENSION 1 FILED
Tuesday, May 2, 2023SOU EXTENSION 1 GRANTED
Thursday, May 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 27, 2023SOU EXTENSION 2 FILED
Wednesday, December 27, 2023SOU EXTENSION 2 GRANTED
Thursday, June 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 27, 2024SOU EXTENSION 3 FILED
Thursday, June 27, 2024SOU EXTENSION 3 GRANTED
Friday, December 27, 2024SOU TEAS EXTENSION RECEIVED
Friday, December 27, 2024SOU EXTENSION 4 FILED
Friday, December 27, 2024SOU EXTENSION 4 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 11, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 20, 2025USE AMENDMENT FILED
Tuesday, May 20, 2025TEAS STATEMENT OF USE RECEIVED
Friday, June 27, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, July 8, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, July 16, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

auron cancer treatment preparations pharmaceutical